PM360

OCTOBER 26, 2023

Klick Health announced that admired market access professional Ellen Cappellino has joined the agency to further build out its value, access, and reimbursement capabilities and help transform the healthcare experience for patients. I was drawn to Klick’s world-class team and technological capabilities,” she explained. “I

Marketing 52

Marketing Healthcare Healthcare Consulting 52

Clarity Engagement Solutions

NOVEMBER 9, 2020

Thus, market access involved little engagement with a small set of stakeholders.In emerging markets, market access as a corporate function is still not as well structured as it is in developed markets.In Thus, market access involved little engagement with a small set of stakeholders.In

Marketing 91

Marketing Key account management Pharma Prescription 91

Clarity Engagement Solutions

NOVEMBER 9, 2020

Thus, market access involved little engagement with a small set of stakeholders.In emerging markets, market access as a corporate function is still not as well structured as it is in developed markets.In How do these elements apply to new types of decision makers, previously unknown to market access teams?

Marketing 91

Marketing Key account management Pharma Prescription 91

PM360

NOVEMBER 12, 2023

market, emerging markets present great opportunities for biotech and pharmaceutical companies. Development—and in particular, urbanization—means these markets offer greater potential than in the past. These markets often have larger populations than more established markets and higher population growth.

Marketing 59

Marketing Biopharma Government Pharma 59

Pharmaceutical Technology

MAY 26, 2023

The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. There are currently over 700 immuno-oncology products in Phase I-III of development in the eight major markets, said Chalk.

Marketing 105

Marketing Physicians Insurance Pharmaceutical 105

Tribeca Knowledge

DECEMBER 12, 2023

E very product needs a market. It also needs market access. In our pharma trends for 2024, we look at some critical market access challenges in key territories for industry, and how companies can best prepare for them over the coming year.

Marketing 52

Marketing Pharma Pharmaceutical 52

PM360

APRIL 7, 2023

When comparing the challenges presented in emerging markets with more mature markets, the obvious starting point is healthcare expenditure. Having less to spend means a difference in priorities for governments—the focus in emerging markets continues to be more on building capacity in both physical infrastructure and human capital.

Marketing 52

Marketing Government Insurance Healthcare 52

Pharmaceutical Technology

JULY 20, 2023

Ahead of APEC’s "Rare disease vision 2025" deadline, Asian countries are working at different speeds towards improving drug market access.

Marketing 75

Marketing 75

eMediWrite

AUGUST 2, 2023

Globally, market access has drawn a lot of attention as nations struggle to control their rising healthcare costs amid the international economic downturn. Additionally, emerging markets are currently the primary drivers of growth, making success in these areas crucial for the bulk of pharmaceutical businesses.

Marketing 52

Marketing Management Key account management Healthcare 52

Clarify Health

AUGUST 22, 2022

Market Access Interview. While pharma companies are continuously innovating internal processes and implementing novel technologies to gain efficiencies across R&D and commercial, one function has lagged the others: market access reporting. Interviewer: Rachael Hellman. Interviewee: Colin Taggart.

Marketing 52

Marketing Pharma Consulting Insurance 52

Medical Device Success

JULY 4, 2021

Failure to plan for market access early is one of the key causes of company underperformance and failure” , according to April whose team at TTi Health Research & Economics has helped companies recover from their lack of preparedness. TTi Health Research & Economics Market Readiness Assessment link. You won’t regret it.

Marketing 130

Marketing Medical Sales 130

PM360

APRIL 7, 2023

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Understanding and interpreting access restrictions and the true downstream impact will inform manufacturer market access and contracting teams in negotiations.”

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

PharmExec

JANUARY 26, 2023

As pharmaceutical market access teams head into 2023, these ten trends detail why evolved preparation, thought, and engagement will be needed to meet post-pandemic marketplace expectations.

Marketing 52

Marketing Pharmaceutical 52

PharmExec

APRIL 7, 2023

Fingerpaint Group further enforces its commitment to the space, marking its second market access acquisition in three years.

Marketing 52

Marketing 52

PharmExec

APRIL 18, 2023

German laws, European VBCs, and trends in China, Brazil, and Saudi Arabia are changing the way global market access works.

Marketing 52

Marketing Pharma 52

PM360

APRIL 7, 2023

With new “disruptive” market entrants, how does the PBM landscape change, how are consumer perceptions altered, and how do pharma marketers stay ahead of the game to deliver differentiated value for brands? For the last 30 years or so, the pharmaceutical landscape has been dominated by pharmacy benefit managers (PBMs).

Marketing 52

Marketing Prescription Insurance Retail 52

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Not only that, One Medical accepts insurance and partners with local health systems in most markets where it operates.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarify Health

AUGUST 22, 2022

Market Access Interview Interviewer: Rachael Hellman Interviewee: Colin Taggart While pharma companies are continuously innovating internal processes and implementing novel technologies to gain efficiencies across R&D and commercial, one function has lagged the others: market access reporting.

Marketing 40

Marketing Pharma Consulting Insurance 40

Clarify Health

JULY 14, 2022

Clarify Health, a leading cloud analytics and value-based payments platform company, announced the launch of Clarify Access , real-world insights software that helps life sciences companies strengthen market access strategies and improve reporting efficiency through the delivery of on-demand reporting and payer insights.

Marketing 59

Marketing Pharma Patients Leads 59

Pharmaceutical Technology

AUGUST 8, 2023

Pricing and reimbursement of pharmaceuticals is changing in Sweden, with prices lower than average as a result of growing cost containment strategies. Here’s what you need to know.

Marketing 52

Marketing Pharmaceutical 52

Pharmaceutical Commerce

OCTOBER 5, 2022

Wednesday, October 5, 2022, 11am EDT Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. Get answers to eleven key questions that will help guide commercial teams in effectively launching specialty products.

Marketing 52

Marketing 52

Clarify Health

JULY 14, 2022

With Clarify Access, pharma teams can more rapidly adjust market access strategies, instantly pinpoint formulary advantages and weaknesses to better enable their field force and save time during contract negotiations with specific payers.

Marketing 52

Marketing Pharma Patients Leads 52

Dominic Tyer

MAY 3, 2021

The new episode of the pharmaphorum podcast also hears about some of pharma’s UK launch challenges and the types of evidence that HTA bodies need for RNA-based drugs.

Marketing 130

Marketing Pharma 130

PharmExec

OCTOBER 18, 2022

Commercial Health Insurance may bring more opportunities for market access in China.

Insurance 52

Insurance Marketing 52

pharmaphorum

JUNE 12, 2017

Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans.

Marketing 52

Marketing Engineering Biopharma Prescription 52

PharmExec

MAY 10, 2023

BCG’s 2022 benchmark study uncovers new competencies needed for pharma access leaders in enterprise-wide business strategy, where thoughtfully designed approaches and goals focused on shared priority and responsibility are increasingly important.

Marketing 116

Marketing Pharma 116

Fierce Pharma

OCTOBER 9, 2023

How can marketers leverage AI to make sense of the masses of data they have access to? The way we consume and engage with content is changing all the time. | Chris Paquette, Founder and CEO of DeepIntent, explores the issues of fragmentation and outlines some of the tools designed to overcome it.

Marketing 255

Marketing 255

PharmExec

JULY 27, 2022

Using data visualizations to improve access to payers.

Marketing 96

Marketing 96

PharmExec

NOVEMBER 14, 2022

The move reflects Fingerpaint Group's commitment to innovate its capabilities as clients' needs evolve.

Marketing 52

Marketing 52

PharmExec

APRIL 5, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Marketing 52

Marketing Pharma Patients 52

Fierce Pharma

JUNE 15, 2023

market, one of the biggest manufacturers of the copycat biologics has unveiled a plan to boost uptake across the globe. Sandoz' Act4Biosimilars action plan includes a detailed report of challenges preventing wider biosimilar access in each region, starting with the Americas. As biosimilars gradually gain steam in the U.S.

Manufacturing 246

Manufacturing Marketing 246

Pharmacy Times

SEPTEMBER 5, 2023

Manufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.

Insurance 49

Insurance Marketing Pharmaceutical Manufacturing 49

MedCity News

APRIL 8, 2024

The expanded FDA approvals makes these cell therapies more accessible to more patients, broadening the market for both products. The CAR T-therapies Abecma and Carvykti may now be used in earlier lines of treatment for multiple myeloma.

FDA 125

FDA Patients Marketing Biopharma 125

PharmExec

DECEMBER 11, 2023

Five emerging themes likely to impact pharma in the new year.

Marketing 52

Marketing Pharma 52

PM360

NOVEMBER 27, 2023

In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their combinations in today’s environment. Status Quo: The Core Issue In oncology, it has been the “status quo” for combination therapies to face challenges with respect to pricing and access.

Manufacturing 111

Manufacturing Marketing Competition Patients 111

PM360

AUGUST 24, 2023

Most market access teams at pharmaceutical and biotech manufacturers have the same problem: evidence of clinical effectiveness isn’t always enough to affect prescribing behavior, often due to—accurate or misperceived—access and affordability concerns. For pharma, it can sometimes feel like a situation beyond their control.

Pharma 98

Pharma Physicians Marketing Insurance 98

PharmaTech

MAY 18, 2023

UK's NICE has recommended RINVOQ (upadacitinib) as a treatment option for adult patients in England and Wales with moderately to severely active Crohn’s disease.

Marketing 52

Marketing Patients 52